Bespoke Extracts, Inc. Files 2023 Annual Report on Form 10-K

TL;DR

<b>Bespoke Extracts, Inc. has filed its 2023 annual report on Form 10-K, confirming its status as a smaller reporting company.</b>

AI Summary

Bespoke Extracts, Inc. (BSPK) filed a Annual Report (10-K) with the SEC on April 18, 2024. Bespoke Extracts, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023. The company is incorporated in Nevada and its principal executive offices are located in Aurora, Colorado. Bespoke Extracts, Inc. is classified as a smaller reporting company and a non-accelerated filer. The company has submitted all required reports for the preceding 12 months and has been subject to filing requirements for the past 90 days. Bespoke Extracts, Inc. has submitted electronically every Interactive Data File required for the preceding 12 months.

Why It Matters

For investors and stakeholders tracking Bespoke Extracts, Inc., this filing contains several important signals. This filing provides a comprehensive overview of the company's financial performance and operational status for the fiscal year 2023. As a smaller reporting company, Bespoke Extracts, Inc. may have less stringent disclosure requirements compared to larger filers, impacting the depth of information available to investors.

Risk Assessment

Risk Level: low — Bespoke Extracts, Inc. shows low risk based on this filing. The filing is a standard 10-K, indicating routine disclosure rather than significant new information or events that would alter the risk profile.

Analyst Insight

Investors should review the full 10-K filing for detailed financial statements, risk factors, and management discussion to assess the company's current standing and future prospects.

Key Numbers

• 20231231 — Fiscal Year End (Conformed period of report)
• 20240418 — Filing Date (Filed as of date)
• 000-52759 — Commission File Number (SEC File Number)

Key Players & Entities

• Bespoke Extracts, Inc. (company) — Registrant
• 2023 (date) — Fiscal year ended
• December 31 (date) — Fiscal year ended
• 20240418 (date) — Filed as of date
• Nevada (jurisdiction) — State of incorporation
• Aurora, CO (location) — Address of principal executive offices
• 000-52759 (filing_id) — Commission file number
• 20-4743354 (tax_id) — I.R.S. Employer Identification No.

FAQ

Industry Context

Bespoke Extracts, Inc. operates within the pharmaceutical preparations industry, as indicated by its SIC code 2834.

Regulatory Implications

The filing is a standard Form 10-K, adhering to the reporting requirements of the Securities Exchange Act of 1934.

What Investors Should Do

1. Review the full 10-K for detailed financial statements and operational disclosures.
2. Analyze the company's business description and risk factors for potential investment insights.
3. Compare the 2023 results with previous filings to identify trends and changes.

Year-Over-Year Comparison

This filing is the annual report for fiscal year 2023, following previous filings which would include quarterly reports and potentially prior annual reports.

Key Financial Figures

• $0.001 — g) of the Act: Common Stock, par value $0.001 per share Indicate by check mark if t
• $600,000 — e the property underlying the lease for $600,000. On January 3, 2023, the Company close

Filing Documents

• ea0202767-10k_bespoke.htm (10-K) — 795KB
• ea020276701ex21-1_bespoke.htm (EX-21.1) — 0KB
• ea020276701ex31-1_bespoke.htm (EX-31.1) — 11KB
• ea020276701ex32-1_bespoke.htm (EX-32.1) — 3KB
• fin_001.jpg (GRAPHIC) — 6KB
• fin_002.jpg (GRAPHIC) — 5KB
• 0001213900-24-033935.txt (&nbsp;) — 4756KB
• bspk-20231231.xsd (EX-101.SCH) — 55KB
• bspk-20231231_cal.xml (EX-101.CAL) — 34KB
• bspk-20231231_def.xml (EX-101.DEF) — 261KB
• bspk-20231231_lab.xml (EX-101.LAB) — 479KB
• bspk-20231231_pre.xml (EX-101.PRE) — 257KB
• ea0202767-10k_bespoke_htm.xml (XML) — 361KB

Signatures

Signatures 29 i PART I This Annual Report on Form 10-K may contain forward-looking statements. Such forward-looking statements are based on our management's beliefs and assumptions and on information currently available to our management and involve risks and uncertainties. Forward-looking statements include statements regarding our plans, strategies, objectives, expectations, and intentions, which are subject to change at any time at our discretion. Forward-looking statements include our assessment, from time to time of our competitive position, the industry environment, potential growth opportunities and the effects of regulation. Forward-looking statements include all statements that are not historical facts and can be identified by terms such as "anticipates," "believes," "could," "estimates," "expects," "hopes," "intends," "may," "plans," "potential," "predicts," "projects," "should," "will," "would" or similar expressions.

Forward-looking statements

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We discuss many of these risks in greater detail in "Risk Factors." Given these uncertainties, undue reliance should not be placed on these forward-looking statements. Also, forward-looking statements represent our management's beliefs and assumptions only as of the date of this report. Our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update these forward-looking statements publicly. As used in this annual report, the terms "we", "us", "our", the "Company", "Bespoke Extracts, Inc." and "Bespoke" mean Bespoke Extracts, Inc. unless otherwise indicated.

Business

Item 1. Business. Background Bespoke Extracts, Inc. is a Nevada corporation. The Company's Common Stock (as hereinafter defined) is traded in the United States on the OTCQB (the "OTCQB") under the symbol "BSPK." The Company has one wholly-owned subsidiary, Bespoke Extracts Colorado, LLC ("Bespoke Colorado"). Originally founded in 1988, Bespoke began operations in the cannabis industry in 2023 upon the acquisition of a state-licensed adult-use marijuana infused products business in Aurora, Colorado. The Company has since begun producing pre-rolled marijuana cigarettes, or "pre-rolls". Currently, Bespoke owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Box-O-Joints, and Wee Joints , to licensed marijuana dispensaries across Colorado. Our Corporate History For information on the history of the Company and the development of the business prior to November, 2021, the month new management was appointed, see the information set forth under the headings "Business – Our Corporate History" in our Form 10-K that was filed with the SEC on April 27, 2023. In November 2021, new management of the Company was appointed and the Company began to focus on other complimentary lines of business to its historical CBD offerings, specifically regulated cannabis. Under our new management team, we plan to expand the Company's focus to regulated cannabis markets in the United States. In furtherance of its expanded strategy, on January 3, 2023, the Company closed on its acquisition of WonderLeaf assets and they are now owned and operated by Bespoke Colorado. Following the success of the Company's cannabis efforts, the Company has discontinued its CBD efforts. The Company's expanded business plan may include the acquisition of related businesses in additional states which allow publicly traded companies to own and operate such businesses. Depending on the markets entered and state regulation, the Company's plan may al

View Full Filing

View this 10-K filing on SEC EDGAR